Compile Data Set for Download or QSAR
Report error Found 68 Enz. Inhib. hit(s) with all data for entry = 8186
TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM50181008(TMI-05 | (S)-N-hydroxy-4-(4-(4-hydroxybut-2-ynylox...)
Affinity DataIC50: 5nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetStromelysin-1(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM50181008(TMI-05 | (S)-N-hydroxy-4-(4-(4-hydroxybut-2-ynylox...)
Affinity DataIC50: 10nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113593(US8633196, 26 | US9365529, 26)
Affinity DataIC50: 16nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113592(US8633196, 24 | US9365529, 24)
Affinity DataIC50: 16nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113577(US8633196, 14 | US8633196, 5 | US9365529, 5)
Affinity DataIC50: 21nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113583(US8633196, 11 | US9365529, 11)
Affinity DataIC50: 24nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113574(US8633196, 2 | US9365529, 2)
Affinity DataIC50: 32nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113593(US8633196, 26 | US9365529, 26)
Affinity DataIC50: 33nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113589(US8633196, 19 | US9365529, 19)
Affinity DataIC50: 41nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113582(US8633196, 10 | US9365529, 10)
Affinity DataIC50: 47nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113578(US8633196, 6 | US9365529, 6)
Affinity DataIC50: 52nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113591(US8633196, 23 | US9365529, 23)
Affinity DataIC50: 53nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113587(US8633196, 17 | US9365529, 17)
Affinity DataIC50: 62nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113590(US8633196, 21 | US9365529, 21)
Affinity DataIC50: 63nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113577(US8633196, 14 | US8633196, 5 | US9365529, 5)
Affinity DataIC50: 64nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113588(US8633196, 18 | US9365529, 18)
Affinity DataIC50: 67nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 10(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM50181008(TMI-05 | (S)-N-hydroxy-4-(4-(4-hydroxybut-2-ynylox...)
Affinity DataIC50: 71nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetMatrix metalloproteinase-9(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM50181008(TMI-05 | (S)-N-hydroxy-4-(4-(4-hydroxybut-2-ynylox...)
Affinity DataIC50: 82nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 9(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM50181008(TMI-05 | (S)-N-hydroxy-4-(4-(4-hydroxybut-2-ynylox...)
Affinity DataIC50: 85nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113592(US8633196, 24 | US9365529, 24)
Affinity DataIC50: 86nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113573(US8633196, 1 | US9365529, 1)
Affinity DataIC50: 87nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113584(US8633196, 13 | US9365529, 13)
Affinity DataIC50: 108nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113580(US8633196, 8 | US9365529, 8)
Affinity DataIC50: 127nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM235932(US9365529, 20)
Affinity DataIC50: 140nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetInterstitial collagenase(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM50181008(TMI-05 | (S)-N-hydroxy-4-(4-(4-hydroxybut-2-ynylox...)
Affinity DataIC50: 145nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113581(US8633196, 9 | US9365529, 9)
Affinity DataIC50: 147nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113586(US8633196, 16 | US9365529, 16)
Affinity DataIC50: 168nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 17(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113576(US8633196, 4 | US9365529, 4)
Affinity DataIC50: 497nMpH: 7.4 T: 2°CAssay Description:The TACE enzyme is an internal production (carried out according to the publication protein Eng Des Sel 2006, 19, 155-161) and is added so as to have...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetStromelysin-1(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113593(US8633196, 26 | US9365529, 26)
Affinity DataIC50: 574nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetInterstitial collagenase(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113588(US8633196, 18 | US9365529, 18)
Affinity DataIC50: 670nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetStromelysin-1(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113588(US8633196, 18 | US9365529, 18)
Affinity DataIC50: 849nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetStromelysin-1(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113590(US8633196, 21 | US9365529, 21)
Affinity DataIC50: 887nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetInterstitial collagenase(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113593(US8633196, 26 | US9365529, 26)
Affinity DataIC50: 969nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetStromelysin-1(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113591(US8633196, 23 | US9365529, 23)
Affinity DataIC50: 1.07E+3nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetInterstitial collagenase(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113590(US8633196, 21 | US9365529, 21)
Affinity DataIC50: 1.17E+3nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetStromelysin-1(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113589(US8633196, 19 | US9365529, 19)
Affinity DataIC50: 1.77E+3nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetStromelysin-1(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113592(US8633196, 24 | US9365529, 24)
Affinity DataIC50: 1.88E+3nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetInterstitial collagenase(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113592(US8633196, 24 | US9365529, 24)
Affinity DataIC50: 2.06E+3nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetInterstitial collagenase(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113591(US8633196, 23 | US9365529, 23)
Affinity DataIC50: 2.22E+3nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetInterstitial collagenase(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113589(US8633196, 19 | US9365529, 19)
Affinity DataIC50: 2.30E+3nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 9(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113589(US8633196, 19 | US9365529, 19)
Affinity DataIC50: 3.05E+3nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetStromelysin-1(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113577(US8633196, 14 | US8633196, 5 | US9365529, 5)
Affinity DataIC50: 3.20E+3nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetInterstitial collagenase(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM235932(US9365529, 20)
Affinity DataIC50: 3.94E+3nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetStromelysin-1(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM235932(US9365529, 20)
Affinity DataIC50: 4.78E+3nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetInterstitial collagenase(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113577(US8633196, 14 | US8633196, 5 | US9365529, 5)
Affinity DataIC50: 5.10E+3nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 9(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113588(US8633196, 18 | US9365529, 18)
Affinity DataIC50: 9.25E+3nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 10(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113591(US8633196, 23 | US9365529, 23)
Affinity DataIC50: 1.00E+4nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 10(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113592(US8633196, 24 | US9365529, 24)
Affinity DataIC50: 1.00E+4nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 10(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM235932(US9365529, 20)
Affinity DataIC50: 1.00E+4nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

TargetDisintegrin and metalloproteinase domain-containing protein 10(Human)
Galderma Research & Devlopment

US Patent
LigandPNGBDBM113590(US8633196, 21 | US9365529, 21)
Affinity DataIC50: 1.00E+4nMAssay Description:The molecules are dose-response tested on the following enzymes: MMP1, MMP3, MMP9, ADAM9 and ADAM10, according to the same protocol as that described...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/3/2017
Entry Details
US Patent

Displayed 1 to 50 (of 68 total ) | Next | Last >>
Jump to: